NB3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neurocrine Biosciences Inc

Watchlist Manager

Watchlist

Price: 151.1 EUR 0.73% Market Closed

Market Cap: €8.5B

N	Neurocrine Biosciences Inc XMUN:NB3	US
S	Showa Denko KK F:SWD	JP
P	Pegasystems Inc F:PEA	US
A	Altea Green Power SpA MIL:AGP	IT
	La Francaise de l Energie SA PAR:FDE	FR
	Fluence Energy Inc NASDAQ:FLNC	US
J	Jefferies Financial Group Inc DUS:LN3	US
	Highland Copper Company Inc XTSX:HI	CA
	Adyen NV OTC:ADYEY	NL
	Iterum Therapeutics PLC NASDAQ:ITRM	IE
	Ferrovial SA MAD:FER	ES

Profitability Summary

Neurocrine Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

98% > 98%

Healthy Operating Margin

26%

Sustainable 3Y Average Operating Margin

22%

Operating Margin is Increasing

18% > 26%

Healthy Net Margin

22%

Sustainable 3Y Average Net Margin

15%

Net Margin is Increasing

11% > 22%

Exceptional Free Cash Flow Margin

27%

Strong 3Y Average Free Cash Flow Margin

23%

Free Cash Flow Margin is Increasing

17% > 27%

Positive ROE

23%

Positive 3Y Average ROE

Positive 3Y Average ROIC

22%

ROIC is Increasing

19% > 20%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.